BROOKSUpdated 5 Sept 2026, 9:29

Brooks Lab Limited

BROOKSUpdated 5 Sept 2026, 9:29

Market Cap

₹195Cr.

Current Price

₹66.1

High / Low

₹164/36.3

Stock P/E

42.6

ROE4.68%

ROCE5.04%

Book Value₹41.0

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 2002, Brooks Laboratories Ltd is a pharmaceutical company working on contract basis catering to the critical care segment[1]

Quarterly results

Last reported quarters₹ Cr.

Annual statement₹ Cr.

As of Jun 2026%

Ownership over time%

Assets & liabilities₹ Cr.

Operating, investing & financing₹ Cr.

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	82.63	86.27	67.81	66.70	75.75	81.50	45.66	71.27	83.79	74.94	88.38	68.58
Inventory Days	45.32	46.12	75.53	103.93	93.03	107.30	91.81	119.53	99.41	60.49	60.56	76.83
Days Payable	114.65	108.29	180.19	242.76	251.23	203.15	99.30	185.53	205.59	97.25	89.65	79.76
Cash Conversion Cycle	13.30	24.09	-36.85	-72.12	-82.45	-14.35	38.17	5.28	-22.39	38.18	59.28	65.65
Working Capital Days	41.64	-0.96	-26.83	-76.92	-125.82	-49.28	-5.86	2.37	-42.65	33.57	43.28	34.31
ROCE %	7.24%	9.58%	2.59%	-10.64%	-8.72%	-6.72%	-5.15%	1.49%	-11.07%	3.45%	4.29%	5.04%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 5 September 2026 at 9:29